GENE ONLINE|News &
From Cancer Therapies to Probiotics: Taiwan’s Three-Pillar Biotech Strategy, Explained
Regional partnerships with Japan, South Korea, and Singapore strengthen Taiwan’s biotech ecosystem and position Asia as a counterbalance to Western dominance. Image: GeneOnline
Taiwan faces the same health crossroads as many nations today: an aging population, rising rates of chronic disease, and the looming threat of future pandemics. At the same time, it must find ways to compete in the global biotech race while ensuring its own people benefit from cutting-edge science. For Tsai-Kun Li (TK Li), President … From Cancer Therapies to Probiotics: Taiwan’s Three-Pillar Biotech Strategy, Explained Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
